Latest News
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds First Solar (FSLR) Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In First Solar To Contact Him Directly To Discuss Their Options If you purchased or acqu
BE INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Bloom Energy (BE) Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bloom Energy To Contact Him Directly To Discuss Their Options If you purchased or acq
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ZoomInfo (GTM) Investors of Securities Class Action Lawsuit Deadline on August 24, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ZoomInfo To Contact Him Directly To Discuss Their Options If you purchased or acquire
HUBG INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Hub Group (HUBG) Investors of Securities Class Action Lawsuit Deadline on August 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hub Group To Contact Him Directly To Discuss Their Options If you purchased or acquir
YETI: Cold Reaction Heading Into The Fall
YETI Holdings remains a compelling buy after a post-earnings sell-off, with shares now trading within my fair value range of $40.57–$47.87. YETI continues to deliver strong fundamentals: 59% gross mar
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook
Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, an
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Embecta To Contact Him Directly To Discuss Their Options If you purchased or acquir
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Futu Holdings Limited (FUTU) Investors of Securities Class Action Lawsuit Deadline on August 25, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Futu To Contact Him Directly To Discuss Their Options If you purchased or acquired se
REGN INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Regeneron To Contact Him Directly To Discuss Their Options If you purchased or acquir
BZAI INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Blaize Investors of Securities Class Action Lawsuit Deadline on October 5, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blaize To Contact Him Directly To Discuss Their Options If you purchased or acquired
RXT INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Rackspace Technology (RXT) Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rackspace To Contact Him Directly To Discuss Their Options If you purchased or acquir
Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts
Ocugen NASDAQ: OCGN is positioning its ophthalmology gene therapy portfolio around treatments for inherited retinal diseases and dry age-related macular degeneration, with pivotal-stage programs in re
Harvard makes massive $2.2B SpaceX bet on Elon Musk's rocket company
Harvard Management Company revealed a $2.2 billion SpaceX stake as university endowments benefit from early investments in Elon Musk's rocket company
Richards Group Inc. Announces Change of Auditor
Toronto, Ontario--(Newsfile Corp. - August 15, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") today announced that its Board
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Black Rock Coffee (BRCB) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Black Rock Coffee To Contact Him Directly To Discuss Their Options If you purchased o
NXP Semiconductors Sees Demand Rebound as Auto, AI and Data Center Growth Accelerate
NXP Semiconductors NASDAQ: NXPI sees a meaningfully improved business environment compared with 90 days ago and a year ago, with book-to-bill ratios solidly above one across its end markets, according
BTU DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Peabody Energy Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 24 Deadline in Securities Class Action - BTU
New York, New York--(Newsfile Corp. - August 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Peabody Energy Corporation (NYSE: BTU) between Oc
CAR Investors Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit Against Pentwater Capital Management LP
NEW YORK, Aug. 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDA
INTU DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Intuit Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - INTU
New York, New York--(Newsfile Corp. - August 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intuit Inc. (NASDAQ: INTU) between August 22, 2025
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference
Natera NASDAQ: NTRA Chief Financial Officer Mike Brophy said the company delivered strong second-quarter momentum across its women's health, oncology and organ health businesses, citing record Signate